Gabapentinoid Use Tied to Higher Risk for Hip Fractures
Associations especially strong in patients who are frail or have chronic kidney disease
FDA Approves Cobenfy for Adults With Schizophrenia
Approval marks first new class of treatment in decades and the first muscarinic agonist
President-Elect Trump Nominates Robert F. Kennedy Jr. to Lead HHS
RFK Jr. has courted controversy in recent years with his views on vaccines, fluoride in drinking water, unpasteurized milk
Big Post-Election Surge Seen in Online Sales of Morning-After Pills
AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke...
Findings seen in patients with ischemic stroke; associations were significant after multivariable adjustment
FDA Approves Emrosi for Rosacea in Adults
Phase 3 trials show significant reduction in total lesion count versus Oracea and placebo
SGLT-2 Inhibitors Beneficial for Patients With Nephrolithiasis
Reduction seen in recurrent nephrolithiasis events for those receiving SGLT-2 inhibitors versus GLP-1 RAs, DPP-4 inhibitors
Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu Shots
Primary composite reactogenicity outcome noninferior for those receiving both vaccines simultaneously
Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide
Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
Impact of expanding access to GLP-1 receptor agonists, dual gastric inhibitory polypeptide and GLP-1 receptor agonists quantified
